SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the 28th Annual J.P. Morgan Healthcare Conference to be held on January 11-14, 2010 in San Francisco. Jonathan Lim, M.D., president and CEO, will present an overview of Halozyme and its product development pipeline on Wednesday, January 13, 2010 at 11:30 a.m. PST (2:30 p.m. EST).
